Key Laboratory of Medicinal Chemistry for Natural Resource (Yunnan University), Ministry Education, School of Chemical Science and Technology, Yunnan University, Kunming 650091, PR China.
Bioorg Med Chem Lett. 2013 Nov 1;23(21):5958-63. doi: 10.1016/j.bmcl.2013.08.068. Epub 2013 Aug 23.
A novel series of polyhalobenzonitrile quinazolin-4(3H)-one derivatives were synthesized and characterized by NMR, IR, MS, and HRMS spectra. All of the newly prepared compounds were screened for antimicrobial activities against four strains of bacteria (Gram-positive bacterial: Staphylococcus aureus and Bacillus cereus; Gram-negative bacterial: Escherichia coli and Pseudomonas aeruginosa) and one strain of fungi (Candida albicans). Among the synthesized compounds, 5-(dimethylamino)-8-(2,4,5-trichloro-isophthalonitrile) quinazolin-4(3H)-one (7k) exhibited significant activity towards Gram-positive bacterial, Gram-negative bacterial, and the fungi strains. The MIC (0.8-3.3μg/mL) and MBC (2.6-7.8μg/mL) for this compound were close to those of nofloxacin, chlorothalonil, and fluconazole, making it the most potent antimicrobial agents in the series.
我们合成了一系列新型多卤苯甲腈喹唑啉-4(3H)-酮衍生物,并通过 NMR、IR、MS 和 HRMS 光谱对其进行了表征。所有新合成的化合物都进行了抗微生物活性筛选,以评估它们对四种细菌(革兰氏阳性菌:金黄色葡萄球菌和蜡状芽孢杆菌;革兰氏阴性菌:大肠杆菌和铜绿假单胞菌)和一种真菌(白色念珠菌)的抑制作用。在所合成的化合物中,5-(二甲基氨基)-8-(2,4,5-三氯异邻苯二甲腈)喹唑啉-4(3H)-酮(7k)对革兰氏阳性菌、革兰氏阴性菌和真菌菌株均表现出显著的活性。该化合物的 MIC(0.8-3.3μg/mL)和 MBC(2.6-7.8μg/mL)与诺氟沙星、百菌清和氟康唑相当,使其成为该系列中最有效的抗菌剂。